Evofem Biosciences, Inc. (EVFM) Discounted Future Market Cap - Discounting Cash Flows
Evofem Biosciences, Inc.
EVFM (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 32.52 USD
Estimated net income -566.5 Bil. USD
Estimated market capitalization 197.6 Bil. USD
Market capitalization discounted to present 198 Bil. USD
Shares Outstanding 6.09 Bil.
Earnings Per Share (EPS) -0.028 USD
Market Price 0.01 USD
Price to Earnings (PE) Ratio -0.359

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue 19.36 16.61 20.02 94.2 443.3 2,086 9,817
Revenue Growth Rate 6.29% -14.24% 3.37% 370.6% 370.6% 370.6% 370.6%
Net Income -8.86 -3.1 -1,155 -5,436 -25,582 -120,388 -566,547

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 13.29 16.61 19.36 18.22 16.84 8.24 0.446 0 0 0 0 0
Cost of Revenue 2.32 3.52 3.83 6.51 4.42 4.05 1.65 0.905 0.262 0.244 0.069 0.058
Gross Profit 4.93 13.09 15.53 11.71 12.42 4.19 -1.2 -0.905 -0.262 -0.244 -0.069 -0.058
Gross Margin 13.03% 78.83% 80.2% 64.26% 73.78% 50.81% -269.7%
Operating Income -54.98 -4.5 -7.68 -17.85 -84.12 -166.8 -103.6 -52.74 -77.64 -35.69 -12.04 -42.05
Operating Margin -4,320% -27.13% -39.64% -97.96% -499.6% -2,023% -23,230%
Net Income -68.22 -3.1 -8.86 52.98 -76.7 -205.2 -142.3 -80.03 -125.7 -105.3 -13.02 -43.16
Net Margin -5,771% -18.64% -45.76% 290.8% -455.5% -2,489% -31,910%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 13.29 16.61 19.36 18.22 16.84 8.24 0.446 0 0 0 0 0
Revenue Growth Rate 370.5% -14.24% 6.29% 8.2% 104.2% 1,748%
Net Income -68.22 -3.1 -8.86 52.98 -76.7 -205.2 -142.3 -80.03 -125.7 -105.3 -13.02 -43.16
Net Margin -5,771% -18.64% -45.76% 290.8% -455.5% -2,489% -31,910%
Net Income Growth Rate 57.23% -65.07% -116.7% -169.1% -62.62% 44.19% 77.81% -36.34% 19.38% 708.9% -69.83% 298.9%
Stockholders Equity -40.39 -64.8 -71.26 -66.51 -71.8 -99.58 1.35 15.64 -23.36 -99.67 11.91 23.81
Equity Growth Rate -810.4% -9.06% 7.14% -7.37% -27.89% -7,492% -91.39% -166.9% -76.57% -936.6% -49.95% -63.51%
Return on Invested Capital (ROIC) 1,899% 7.74% 13.37% 28.55% 117.8% 162.1% 267.3% 22,070% 315% 35.47% -2,758% 624.2%
After-tax Operating Income -54.98 -4.5 -7.68 -17.84 -84.17 -166.8 -103.6 -52.74 -77.64 -35.69 -12.04 -42.05
Income Tax Rate -0.007% 0% 0% 0.032% -0.057% -0.008% -0.003% -0.005% -0.002% -0.003% 0% 0%
Invested Capital -47.54 -58.2 -57.4 -62.49 -71.44 -102.9 -38.77 -0.239 -24.65 -100.6 0.437 -6.74
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us